DK0951289T3 - Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom - Google Patents

Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom

Info

Publication number
DK0951289T3
DK0951289T3 DK97949067T DK97949067T DK0951289T3 DK 0951289 T3 DK0951289 T3 DK 0951289T3 DK 97949067 T DK97949067 T DK 97949067T DK 97949067 T DK97949067 T DK 97949067T DK 0951289 T3 DK0951289 T3 DK 0951289T3
Authority
DK
Denmark
Prior art keywords
treatment
chronic fatigue
fatigue syndrome
mycobacterium vaccae
vaccae
Prior art date
Application number
DK97949067T
Other languages
Danish (da)
English (en)
Inventor
Graham Arthur William Sta Rook
John Lawson Stanford Stanford
Alimuddin Ismail Zumla
Original Assignee
Stanford Rook Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9626215.9A external-priority patent/GB9626215D0/en
Priority claimed from GBGB9626859.4A external-priority patent/GB9626859D0/en
Application filed by Stanford Rook Ltd filed Critical Stanford Rook Ltd
Application granted granted Critical
Publication of DK0951289T3 publication Critical patent/DK0951289T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK97949067T 1996-12-18 1997-12-17 Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom DK0951289T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9626215.9A GB9626215D0 (en) 1996-12-18 1996-12-18 A therapeutic agent and its use
GBGB9626859.4A GB9626859D0 (en) 1996-12-24 1996-12-24 Medical treatment

Publications (1)

Publication Number Publication Date
DK0951289T3 true DK0951289T3 (da) 2006-03-13

Family

ID=26310662

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97949067T DK0951289T3 (da) 1996-12-18 1997-12-17 Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom

Country Status (18)

Country Link
EP (1) EP0951289B1 (fi)
JP (1) JP4358306B2 (fi)
KR (1) KR100533818B1 (fi)
CN (1) CN1129453C (fi)
AP (1) AP1044A (fi)
AT (1) ATE307600T1 (fi)
AU (1) AU730548B2 (fi)
BR (1) BR9713959A (fi)
CA (1) CA2273848C (fi)
DE (1) DE69734461T2 (fi)
DK (1) DK0951289T3 (fi)
ES (1) ES2251744T3 (fi)
FI (1) FI120136B (fi)
HK (1) HK1021316A1 (fi)
NO (1) NO321202B1 (fi)
NZ (1) NZ336147A (fi)
RU (1) RU2197989C2 (fi)
WO (1) WO1998026790A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361776B1 (en) * 1999-12-06 2002-03-26 Genesis Research & Development Corp. Ltd. Compounds isolated from M. vaccae and their use in modulation of immune responses
US20030180260A1 (en) * 2000-06-19 2003-09-25 Clancy Robert Llewellyn Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
WO2002066055A1 (en) * 2001-02-20 2002-08-29 Maruho Co., Ltd. NOVEL MEDICINAL USE OF α ANTIGEN OR α ANTIGEN GENE
MX2017016931A (es) * 2015-06-24 2018-09-26 Immodulon Therapeutics Ltd Inhibidor del punto de regulacion y un mycobaterium de celula entera para uso en la terapia del cancer.
US11077179B2 (en) 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
AUPM864894A0 (en) * 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders

Also Published As

Publication number Publication date
AP9901553A0 (en) 1999-06-30
FI991384A0 (fi) 1999-06-17
KR100533818B1 (ko) 2005-12-07
NO321202B1 (no) 2006-04-03
JP2001506256A (ja) 2001-05-15
DE69734461D1 (de) 2005-12-01
FI991384A (fi) 1999-06-17
WO1998026790A1 (en) 1998-06-25
ATE307600T1 (de) 2005-11-15
AU7735598A (en) 1998-07-15
NO992957L (no) 1999-08-10
FI120136B (fi) 2009-07-15
EP0951289A1 (en) 1999-10-27
HK1021316A1 (en) 2000-06-09
CN1246056A (zh) 2000-03-01
JP4358306B2 (ja) 2009-11-04
NO992957D0 (no) 1999-06-17
EP0951289B1 (en) 2005-10-26
ES2251744T3 (es) 2006-05-01
AP1044A (en) 2002-02-18
CN1129453C (zh) 2003-12-03
NZ336147A (en) 2001-03-30
CA2273848A1 (en) 1998-06-25
DE69734461T2 (de) 2006-07-06
CA2273848C (en) 2008-02-19
KR20000069518A (ko) 2000-11-25
AU730548B2 (en) 2001-03-08
RU2197989C2 (ru) 2003-02-10
BR9713959A (pt) 2000-04-11

Similar Documents

Publication Publication Date Title
DK0937016T3 (da) Behandling af kulbrintegas
DK1632234T3 (da) (S,S)-reboxetin til behandling af kronisk træthedssyndrom
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK0752870T3 (da) Anvendelse af Mycobacterium til behandling af tumorer
DE59508805D1 (de) Schwingungsdämpfendes Bau- oder Funktionselement
DK0973596T3 (da) Filteranordning med filterskiver
DK199800837A (da) Anlæg til behandling af emner
DK0928183T3 (da) Anvendelse af 1-hydroxy-2-pyridoner til behandling af seborrhoisk dermatitis
DK0584247T3 (da) Sammensætninger til behandling af kronisk træthedssyndrom
DK0951289T3 (da) Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom
DE60027068D1 (de) Klemme zum Befestigen von Rohren oder ähnlichem
ES1024417Y (es) Dispositivo manual para tratamiento de iontoforesis.
DK1011678T3 (da) Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser
FI3488U1 (fi) Pitolaite
FI960865A0 (fi) Laite pintojen työstämistä varten
ES1027065Y (es) Dispositivo perfeccionado para la constitucion de cajones de muebles.
DK0737068T3 (da) 2,3-diaryl-1-benzopyraner til behandling af dermatitis
KR970049899U (ko) 수전금구 표면처리 대체 구조물
ES1030366Y (es) Rebosadero perfeccionado, para bañeras y similares.
FI962173A0 (fi) Med bladskydd foersedd saogstaellning
FI962482A0 (fi) Hirsielementti
KR970004046U (ko) 수평상태를 조정할 수 있는 장농
ES1034716Y (es) Mampara para baño perfeccionada.
ES1029741Y (es) Acupresor para acupuntura.
ES1027311Y (es) Dispositivo de fijacion para paneles, plafones y similares.